company background image
002932 logo

Wuhan Easy Diagnosis BiomedicineLtd SZSE:002932 Stock Report

Last Price

CN¥19.56

Market Cap

CN¥4.4b

7D

-1.3%

1Y

-20.7%

Updated

19 Nov, 2024

Data

Company Financials

Wuhan Easy Diagnosis Biomedicine Co.,Ltd.

SZSE:002932 Stock Report

Market Cap: CN¥4.4b

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Wuhan Easy Diagnosis BiomedicineLtd
Historical stock prices
Current Share PriceCN¥19.56
52 Week HighCN¥25.20
52 Week LowCN¥14.81
Beta0.61
11 Month Change9.09%
3 Month Change15.67%
1 Year Change-20.68%
33 Year Change-36.66%
5 Year Change75.56%
Change since IPO106.44%

Recent News & Updates

Recent updates

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) Stock Rockets 26% But Many Are Still Ignoring The Company

Mar 07
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SZSE:002932) Stock Rockets 26% But Many Are Still Ignoring The Company

Shareholder Returns

002932CN Medical EquipmentCN Market
7D-1.3%-5.6%-6.7%
1Y-20.7%-10.2%1.9%

Return vs Industry: 002932 underperformed the CN Medical Equipment industry which returned -10.2% over the past year.

Return vs Market: 002932 underperformed the CN Market which returned 1.9% over the past year.

Price Volatility

Is 002932's price volatile compared to industry and market?
002932 volatility
002932 Average Weekly Movement5.8%
Medical Equipment Industry Average Movement8.6%
Market Average Movement8.2%
10% most volatile stocks in CN Market12.5%
10% least volatile stocks in CN Market5.5%

Stable Share Price: 002932 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 002932's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20081,547Chen Li Liwww.mdeasydiagnosis.com

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer.

Wuhan Easy Diagnosis Biomedicine Co.,Ltd. Fundamentals Summary

How do Wuhan Easy Diagnosis BiomedicineLtd's earnings and revenue compare to its market cap?
002932 fundamental statistics
Market capCN¥4.36b
Earnings (TTM)CN¥10.56m
Revenue (TTM)CN¥349.23m

412.8x

P/E Ratio

12.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
002932 income statement (TTM)
RevenueCN¥349.23m
Cost of RevenueCN¥94.75m
Gross ProfitCN¥254.47m
Other ExpensesCN¥243.91m
EarningsCN¥10.56m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.047
Gross Margin72.87%
Net Profit Margin3.03%
Debt/Equity Ratio0.05%

How did 002932 perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

324%

Payout Ratio